Bisphosphonate use and risk of renal cell carcinoma: A population‐based case‐control study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bisphosphonate use and risk of renal cell carcinoma: A population‐based case‐control study

Published:2019-01-04 Issue:5 Volume:124 Page:642-646
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Chung Benjamin I.¹,Hellfritzsch Maja²³,Ulrichsen Sinna P.³,Sørensen Henrik T.³⁴,Ehrenstein Vera³

Affiliation:

1. Stanford University School of Medicine Stanford California

2. Clinical Pharmacology and Pharmacy, Department of Public Health University of Southern Denmark Odense Denmark

3. Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark

4. Department of Health Research and Policy Stanford University Stanford California

Funder

Lundbeckfonden

Novo Nordisk

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13180

Reference17 articles.

1. Rising Incidence of Renal Cell Cancer in the United States

2. Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer

3. Preclinical Perspectives on Bisphosphonate Renal Safety

4. Renal cell carcinoma

5. Effect of the Women's Health Initiative on Osteoporosis Therapy and Expenditure in Medicaid

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates and risk of cancers: a systematic review and meta-analysis;British Journal of Cancer;2020-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP